order
develop
clinic
diagnost
tool
rapid
detect
sarscov
sever
acut
respiratori
syndromeassoci
coronaviru
identifi
candid
protein
vaccin
develop
ctermin
portion
nucleocapsid
nc
gene
amplifi
use
rtpcr
sarscov
genom
clone
yeast
express
vector
pegh
express
glutathion
stransferas
gst
doubletag
fusion
protein
control
induc
promot
western
analysi
purifi
protein
confirm
express
purif
nc
fusion
protein
yeast
determin
antigen
fusion
protein
challeng
serum
sampl
sar
patient
normal
control
nc
fusion
protein
demonstr
high
antigen
high
specif
therefor
great
potenti
design
clinic
diagnost
tool
provid
use
inform
vaccin
develop
global
outbreak
sever
acut
respiratori
syndrom
sar
year
post
great
threat
public
health
recent
sever
line
evid
demonstr
new
strain
coronavirus
causal
pathogen
infecti
diseas
research
group
manag
rapidli
decod
genom
viru
coupl
clinic
isol
worldwid
thu
provid
foundat
analyz
pathogen
develop
effect
diagnost
tool
therapeut
coronavirus
produc
least
four
structur
protein
name
spike
membran
e
envelop
n
nucleocapsid
antigen
studi
avian
infecti
bronchiti
viru
indic
n
author
contribut
equal
work
correspond
author
email
zhuh
genomicsorgcn
yanghm
genomicsorgcn
protein
one
immunodomin
antigen
induc
crossreact
antibodi
high
titer
wherea
glycoprotein
induc
serotypespecif
crossreact
antibodi
also
report
n
protein
porcin
reproduct
respiratori
syndrom
prr
viru
major
immunogen
viru
sever
domain
antigen
import
n
protein
identifi
monoclon
antibodi
rais
prr
viru
interestingli
delet
amino
acid
cterminu
n
protein
nc
disrupt
epitop
configur
recogn
conformationdepend
monoclon
antibodi
amino
acid
substitut
within
ctermin
domain
reveal
secondari
structur
domain
import
determin
conform
epitop
format
wang
et
al
recent
report
n
protein
could
one
major
antigen
sarscov
special
two
peptid
locat
ctermin
region
n
protein
sarscov
could
recogn
antisera
sar
patient
wang
et
al
press
studi
code
region
ctermin
portion
n
protein
clone
glutathion
stransferas
histidin
fusion
peptid
express
yeast
purifi
fusion
protein
show
posit
signal
probe
sera
sar
patient
western
analysi
use
elisa
enzymelink
immunosorb
assay
approach
purifi
fusion
protein
shown
specif
recogn
sera
sar
patient
neg
control
purif
character
nc
fusion
protein
rtpcr
product
nc
segment
isol
clone
pgemt
vector
recombin
pgemt
pcr
amplifi
yeastclon
primer
pair
verif
dna
sequenc
pcr
product
cotransform
yeast
linear
pegh
vector
yeast
transform
select
proper
media
result
recombin
plasmid
rescu
bacteria
name
peghnc
peghnc
construct
restrict
ecor
determin
whether
insert
right
size
figur
confirm
plasmid
analyz
dna
sequenc
valid
ident
read
frame
confirm
plasmid
reintroduc
yeast
cell
product
fusion
protein
probe
antibodi
western
analysi
lysat
induc
yeast
cell
emerg
band
expect
molecular
weight
fusion
protein
absent
control
carri
empti
vector
indic
nc
fragment
specif
express
proper
yeast
strain
figur
use
gst
affin
tag
fusion
protein
purifi
use
glutathion
agaros
bead
separ
sdspage
sdspolyacrylamid
gel
electrophoresi
coomassi
blue
stain
figur
demonstr
fusion
protein
purifi
high
qualiti
puriti
without
detect
contamin
purifi
fusion
protein
transfer
onto
pvdf
polyvinyliden
fluorid
membran
probe
antisera
sar
patient
detect
antihuman
igg
secondari
antibodi
result
confirm
immunoreact
express
fusion
protein
figur
immunolog
interact
sera
two
individu
sar
patient
gsthisnc
fusion
protein
gave
specif
band
differ
normal
gsthi
fusion
protein
lysat
cell
cultur
contain
sarscov
ls
posit
control
show
strong
band
approxim
kda
sinc
elisa
approach
wide
use
clinic
diagnost
decid
present
nc
protein
elisa
format
determin
whether
use
potenti
detect
tool
clinic
diagnost
purifi
nc
fusion
protein
embed
elisa
plate
incub
sera
taken
four
individu
sar
patient
four
normal
control
result
show
nc
fusion
protein
could
specif
distinguish
sera
sar
patient
sera
normal
control
sera
signific
statist
differ
figur
contrast
signific
differ
observ
result
obtain
nc
fusion
protein
ls
analysi
structur
function
n
protein
sarscov
benefici
understand
life
cycl
pathogen
viru
genet
engin
peptid
would
one
best
way
identifi
genom
segment
associ
antigen
develop
vaccin
defend
sar
variou
method
overproduc
protein
interest
yeast
system
chosen
express
fusion
protein
base
mainli
two
major
consider
first
clone
procedur
simplifi
take
advantag
homolog
recombin
clone
strategi
yeast
restrict
ligat
reactionfre
system
remark
simplifi
clone
procedur
secondli
posttransl
modif
glycosyl
phosphoryl
could
reserv
eukaryot
express
system
properti
may
play
import
role
immunoreact
data
provid
firm
evid
antigen
n
protein
well
preserv
nc
fusion
protein
n
gene
locat
toward
termin
part
sarscov
genom
accord
cotermin
model
subgenom
rna
transcript
part
end
polyadenyl
site
number
transcript
n
protein
would
dramat
larger
upstream
gene
model
establish
coronavirus
recent
confirm
northern
analysi
sarscovcontain
cell
use
termin
probe
cotermin
model
correct
n
gene
cotermin
subgenom
transcript
would
translat
huge
amount
n
protein
addit
nspecif
transcript
unless
possibl
mechan
stop
inhibit
ribosom
bind
site
gene
translat
subgenom
transcript
obviou
viru
invad
host
cell
may
carri
n
protein
outsid
virion
even
though
specif
nonspecif
attach
could
easili
exclud
two
possibl
reason
n
protein
freeli
expos
host
immun
system
first
viru
collaps
inject
genom
host
cell
second
extra
n
protein
bind
genom
rna
fix
molecular
ratio
would
packag
cellular
liquid
bilay
membran
therefor
remain
cytoplasm
host
cell
collaps
n
protein
releas
possibl
mechan
n
protein
engulf
antigen
present
cell
apc
present
cell
adapt
immun
whether
n
protein
involv
process
innat
immun
remain
reveal
sinc
n
protein
shown
import
mani
way
decid
focu
protein
initi
step
toward
better
understand
mechan
diseas
use
yeast
recombin
clone
strategi
abl
rapidli
clone
purifi
ctermin
fragment
n
protein
yeast
cell
western
elisa
analys
demonstr
n
protein
fragment
render
highli
specif
immunorespons
sar
patient
ultim
goal
studi
provid
new
tool
campaign
sar
clone
express
antigen
fragment
viru
advantag
safer
method
use
whole
viru
lysat
largescal
product
antigen
vaccin
immunoreact
nc
fusion
protein
sar
sera
indic
nc
fusion
protein
may
great
potenti
design
clinic
diagnost
tool
rapid
onsit
identif
sar
patient
may
becom
candid
vaccin
sar
sera
sar
patient
normal
control
provid
depart
immunoassay
beij
genom
institut
bgi
cell
lysat
contain
coronavirus
kindli
provid
institut
microbiolog
epidemiolog
chines
academi
militarili
medic
scienc
yeast
strain
yeast
express
vector
pegh
gift
dr
michael
snyder
yale
univers
ncspecif
primer
pair
ncf
aaaggacaaaaagaaaaagact
ncr
aattttacacattagggctcttc
correspond
segment
codon
n
gene
design
base
consensu
sequenc
isol
sarscov
contribut
bgi
genbank
access
number
nucleotid
posit
refer
complet
genom
sequenc
yeastclon
primer
pair
design
attach
vector
sequenc
pegh
genespecif
prime
site
describ
zhu
et
al
synthes
shanghai
dna
biotechnolog
compani
extract
viral
rna
rtpcr
clone
pcr
product
pgemt
plasmid
yeast
cultur
compet
cell
prepar
transform
plasmid
rescu
perform
describ
previous
briefli
rtpcr
product
amplifi
use
nc
primer
pair
clone
pgemt
recombin
pgemt
plasmid
use
templat
pcr
yeastclon
primer
pair
pcr
product
cotransform
yeast
compet
cell
hind
iiixbailinear
pegh
vector
correct
read
frame
recombin
vector
confirm
sequenc
junction
vector
insert
induct
express
purif
fusion
protein
carri
follow
standard
protocol
protein
extract
yeast
cell
separ
sdspage
transfer
onto
pvdf
membran
membran
block
milk
rins
twice
ttb
tri
mm
nacl
mm
ph
incub
ttb
bsa
contain
either
pierc
rockford
usa
sera
sar
patient
primari
antibodi
room
temperatur
h
overnight
membran
wash
ttb
three
time
min
secondari
antibodi
ad
ttb
bsa
room
temperatur
h
alkalin
phosphatas
label
antirabbit
igg
pierc
goat
antihuman
igg
beij
zhongshan
compani
use
secondari
antibodi
detect
human
antibodi
respect
result
visual
incub
membran
mixtur
nbt
bcip
promega
madison
usa
min
elisa
experi
carri
use
convent
protocol
brief
purifi
fusion
protein
mix
sampl
dilut
buffer
embed
elisa
plate
incub
min
well
wash
five
time
wash
buffer
incub
sera
either
sar
patient
normal
control
work
enzym
tracer
ad
well
monitor
bind
fusion
protein
antibodi
signal
detect
nm
elisa
reader
biorad
hercul
usa
